

FOLLOWUS
1. 1Department of Medical Microbiology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China
2. 2Laboratory of Infectious Diseases, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China
*Corresponding author Tel: 86-0719-8891151, E-mail: 151449176@qq.com
Received:17 April 2014,
Published Online:20 June 2017,
Published:2017-06
Scan QR Code
Ou Qin, Li Wenfang, Li Bei, et al. Prevalence of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) and the Distribution of Class 1 Integron in Their Strains Isolated from a Hospital in Central China[J]. Chinese medical sciences journal, 2017, 32(2): 107-112.
Ou Qin, Li Wenfang, Li Bei, et al. Prevalence of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) and the Distribution of Class 1 Integron in Their Strains Isolated from a Hospital in Central China[J]. Chinese medical sciences journal, 2017, 32(2): 107-112. DOI: 10.24920/J1001-9294.2017.018.
目的
研究耐青霉烯类肺炎克雷白杆菌(Carbapenem-Resistant Klebsiella Pneumoniae
CRKP)临床分布
及整合素1在CRKP多药耐药中的作用。
方法
在三年间从中国中部城市一家医院的多个科室采集唾液、血液及多种引流液临床标本
分离肺炎克雷白杆菌并鉴定CRKP。 细菌药敏实验分析CRKP对13中抗生素的耐药情况。PCR扩增CRKP整合素1的可变区域
通过酶切及DNA测序技术分析整合素1可变区域的基因结构。
结果
共955例肺炎克雷白杆菌被分离出
其中CRKP共117例(12.3%)。2013
2014
2015年的Kp菌株中CRKP的分离率分别为8.9% (26/292)
11.31% (38/336)及16.21% (53/327)
呈逐步上升趋势。44.4% (52/117)的CRKP从ICU分离获得
61.5% (72/117)从痰液分离获得。117株CRKP中95% 对氨苄西林/舒巴坦、氨曲南、亚胺培南、美罗培南、头孢他啶、头孢噻肟、头孢吡肟及哌拉西林耐药
但对替加环素和多粘菌素的耐药率较低
分别为12.8%和35.9%。CRKP中整合素1阳性检测率为77.8% (91/117)
整合素1与妥布霉素
庆大霉素及阿米卡星这三种氨基糖苷类抗生素耐药密切相关(P
<
0.01)。整合素1可变区域基因盒检测显示
aadA2占64.84% (59/91)
aacA4 catB8-aadA1占23.1% (21/91)
及aadA2-dfrA25占12.1% (11/91)。
结论
CRKP有逐年增多的趋势
大部分同时具备多药耐药。整合素1介导的耐药基因盒在CRKP对氨基糖苷类抗生素耐药中发挥重要作用
其中aadA2是最常见的耐药基因。
Objective
The aim of our study is to investigate the prevalence of Carbapenem-resistant Klebsiella pneumoniae (CRKP) and the genetic characteristics of the class 1 integron in CRKP on multi-drug resistance.
Methods
Clinical Klebsiella pneumoniae strains were collected from multiple departments of a hospital in central China. CRKP strains were identified among the isolates
and antibiotics susceptibility of CRKP strains was analyzed. The polymerase chain reaction (PCR) was adopted to amplify the class 1 integron variable area. The integron genetic structure was analyzed with enzyme digestion and DNA sequencing technology. The relation between class 1 integron and drug resistance was analyzed statistically.
Results
Totally 955 strains of Klebsiella pneumoniae were isolated from varied sites of the hospital
and 117(12.3%) of them were identified as CRKP
with a separation rate of 8.9% (26/292) in 2013
11.3% (38/336) in 2014 and 16.2% (53/327) in 2015
which shows an increasing trend by year. 44.4% (52/117) of CRKP strains were separated from specimen of ICU
and 61.5% (72/117) were from sputum. Over 95% CRKP strains were resistant to ampicillin/sulbactam
aztreonam
imipenem
meropenem
ceftazidme
cefotaxime
cefepime
and piperacillin
while relatively low resistant rates were found in tigecycline (12.8%) and colistin (35.9%). The class 1 integron was detected in 77.8% (91/117) of CRKP strains. Class 1 integron of CRKP was significantly correlated with the antibiotic resistance to the tobramycin
gentamicin and amikacin (all
P
<
0.01). The gene cassette analysis of variable area of class 1 integron showed that aadA2 accounts for 64.8% (59/91)
aacA4-catB8-aadA1 23.1% (21/91)
and aadA2-dfrA25 12.1% (11/91).
Conclusions
CRKP has an increasing trend in a clinical setting in China
and most of them were resistant to multiple antibiotics. Class 1 integron in CRKP has strong ability to capture the genes resistant to aminoglycosides antibiotics from environment
with the aadA2 gene as the most popular one.
Jia Li , Fei Liu , Qi Wang , et al. Genomic and transcriptomic analysis of NDM-1 Klebsiella pneumoniae in spaceflight reveal mechanisms underlying environmental adaptability. Sci Rep 2014 ; 4 : 6216 . doi: 10.1038/srep06216 10.1038/srep06216 .
Camargo JF , Simkins J , Beduschi T , et al. Successful treatment of Carbapenemase-producing pandrug-resistant Klebsiella pneumoniae bacteremia. Agents Chemother 2015 ; 59 : 5903 - 8 . doi: 10.1128/AAC.00655-15 10.1128/AAC.00655-15 .
Messina JA , Cober E , Richter SS , et al. Hospital readmissions in patients with carbapenem-resistant Klebsiella pneumoniae. Infect Control HospEpidemiol 2016 ; 37 : 281 - 8 . doi: 10.1017/ice.2015.298 10.1017/ice.2015.298 .
Saidel-Odes L , Borer A. Limiting and controlling carbapenem-resistant Klebsiella pneumoniae. Infect Drug Resist 2013 ; 7 : 9 - 14 . doi: 10.2147/IDR.S44358 10.2147/IDR.S44358 .
Liu LT , Wan LH , Song XH , et al. Relevance of class 1 integrons and extended-spectrum β-lactamases in drug- resistant Escherichia coli. Mol Med Rep 2013 ; 8 : 1251 - 5 . doi: 10.3892/mmr.2013.1626 10.3892/mmr.2013.1626 .
Pan YJ , Lin TL , Lin YT , et al. Identification of capsular types in carbapenem-resistant Klebsiellapneumoniae strains by wzc sequencing and implications for capsule depolymerase treatment. Antimicrob Agents Chemother 2015 ; 59 : 1038 - 47 . doi: 10.1128/AAC.03560-14 10.1128/AAC.03560-14 .
Diago-Navarro E , Chen L , Passet V , et al. Carbapenem- resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule associated virulence traits. J Infect Dis 2014 ; 210 : 803 - 13 . doi: 10.1093/infdis/jiu157 10.1093/infdis/jiu157 .
Odumosu BT , Adeniyi BA , Chandra R. Analysis of integrons and associated gene cassettes in clinical isolates of multidrug resistant Pseudomonas aeruginosa from Southwest Nigeria. Ann Clin Microbiol Antimicrob 2013 ; 12 : 29 . doi: 10.1186/1476-0711-12-29 10.1186/1476-0711-12-29 .
Rocha LK , dos Santos Neto RL , da Costa Guimarães AC , et al . Plasmid-mediated qnrA1 in Klebsiella pneumoniae ST147 in Recife, Brazil. Int J Infect Dis 2014 ; 26 : 49 - 50 . doi: 10.1016/j.ijid.2014.04.026 10.1016/j.ijid.2014.04.026 .
Candan ED , Aksöz N. Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factors. ActaBiochim Pol 2015 ; 62 : 867 - 74 . doi: 10.18388/abp.2015_ 1148 10.18388/abp.2015_ 1148 .
Shields RK , Clancy CJ , Hao B , et al. Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae. Antimicrob Agents Chemother 2015 ; 59 : 5793 - 7 . doi: 10.1128/AAC.00548-15 10.1128/AAC.00548-15 .
Guo W , Shan K , Xu B , et al. Determining the resistance of carbapenem-resistant Klebsiella pneumoniae to common disinfectants and elucidating the underlying resistance mechanisms. Pathog Glob Health 2015 ; 109 : 184 - 92 . doi: 10.1179/2047773215Y.0000000022 10.1179/2047773215Y.0000000022 .
Agodi A , Barchitta M , Quattrocchi A , et al. Antibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008-2013. Antimicrob Resist Infect Control 2015 ; 4 : 43 . doi: 10.1186/s13756-015-0087-y 10.1186/s13756-015-0087-y .
Hosan Kim , Inder Makin , Jeff Skiba , et al. Antibacterial efficacy testing of a bioelectric wound dressing against clinical wound pathogens. Open Microbiol J 2014 ; 8 : 15 - 21 . doi: 10.2174/1874285801408010015 10.2174/1874285801408010015 .
Mouloudi E , Massa E , Piperidou M , et al. Tigecycline for treatment of carbapenem-resistant Klebsiella pneumonia infections after liver transplantation in the intensive care unit: a 3-year study. Transplant Proc 2014 ; 46 : 3219 - 21 . doi: 10.1016/j.transproceed.2014.09.160 10.1016/j.transproceed.2014.09.160 .
Lee JY , Choi MJ , Choi HJ , et al. Preservation of acquired colistinresistance in Gram-negative bacteria. Antimicrob Agents Chemother 2015 ; 60 : 609 - 12 . doi: 10.1128/AAC.01574-15 10.1128/AAC.01574-15 .
Chaari A , Mnif B , Chtara K , et al. Efficacy of tigecycline- colistin combination in the treatment of carbapenem- resistant Klebsiella pneumoniae endocarditis. J Glob Antimicrob Resist 2015 ; 3 : 214 - 16 . doi: 10.1016/j.jgar.2015.06.003 10.1016/j.jgar.2015.06.003 .
Yang HS , Fang WL , Lin YT. A case of liver abscess caused by tigecycline-nonsusceptible Klebsiella pneumoniae. J Microbiol Immunol Infect 2016 ; 49 : 621 - 2 . doi: 10.1016/j.jmii.2016.04.010 10.1016/j.jmii.2016.04.010 .
Zeighami H , Haghi F , Hajiahmadi F. Molecular characterization of integronsin clinical isolates of betalactamase producing Escherichia coli and Klebsiella pneumoniaein Iran. J Chemother 2015 ; 27 : 145 - 51 . doi: 10.1179/1973947814Y.0000000180 10.1179/1973947814Y.0000000180 .
Huang YW , Hu RM , Lin YT , et al. The contribution of class 1 integron to antimicrobial resistance in Stenotrophomonasmaltophilia. Microb Drug Resist 2015 ; 21 : 90 - 6 . doi: 10.1089/mdr.2014.0072 10.1089/mdr.2014.0072 .
Yuejin Z , Qingli C , Qian W , et al. Structure and function of class 1 integronin clinical isolates of Klebsiella pneumoniae . Yi Chuan 2014 ; 36 : 603-10 . Chinese. doi: 10.3724/SP.J.1005.2014.0603 10.3724/SP.J.1005.2014.0603 .
Li B , Hu Y , Wang Q , et al. Structural diversity of class 1 integrons and their associated gene cassettes in Klebsiell- a pneumonia isolates from a hospital in China. PLoS One 2013 ; 8 : e75805 . doi: 10.1371/journal.pone.0075805 10.1371/journal.pone.0075805 .
Liu H , Wang H , Huang M , et al. Analysis of antimicrobial resistance and class 1 integrons among strains from upper respiratory tract of healthy adults. J Thorac Dis 2013 ; 5 : 149 - 55 . doi: 10.3978/j.issn.2072-1439.2013.03.09 10.3978/j.issn.2072-1439.2013.03.09 .
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621